U.S. Luxury Stock News

Wondering if CRA International is offering good value right now? Let's take a closer look at the numbers and see what is really going on beneath the surface. The stock has had a mixed run lately, rising 3.0% over the past week but dipping 3.9% in the last month. Longer-term returns show solid growth, like 345.6% over five years. Recently, the company has been in the spotlight after announcing a series of strategic consulting projects and highlighting its expansion into new markets. These...

Frontier Power Ltd. recently announced a 228 megawatt-hour order to deploy Eos Energy Enterprises’ Z3™ energy storage systems, the first conversion under a 5 gigawatt-hour agreement, as part of expanding grid-reliability projects. This milestone underscores increasing commercial adoption of zinc-based, long-duration battery solutions for grid stability as renewable energy penetration grows across multiple markets. We'll explore how this substantial new order highlights growing demand for...

Analog Devices, Inc. recently launched CodeFusion Studio 2.0, a major upgrade to its open source embedded development platform, now featuring end-to-end AI workflow support and advanced multi-core debugging tools across its processor range. This release introduces a unified environment that enables developers to deploy and profile AI models seamlessly on ADI’s hardware, simplifying embedded system complexity and broadening the accessibility of edge AI integration. We'll examine how the...

Fidelis Insurance Holdings (NYSE:FIHL) has caught some attention lately as investors look back on its recent stock performance. The company’s shares have edged up nearly 1% over the past day, reflecting mild gains over the past month. See our latest analysis for Fidelis Insurance Holdings. Momentum around Fidelis Insurance Holdings appears steady, with the share price up 12.4% over the past 90 days and a total shareholder return of 5% for the year. While recent daily moves have been modest,...

MaxLinear, Inc. recently reported its third quarter 2025 financial results and provided fourth quarter guidance, projecting revenue between US$130 million and US$140 million with an expected GAAP gross margin of approximately 56.0% to 59%. An important detail is MaxLinear's year-over-year improvement in both sales and reduced net loss, suggesting operational progress amid ongoing industry challenges. We'll explore how MaxLinear's improved sales and updated margin guidance might affect the...

Carrier Global (CARR) shares have seen some movement recently, catching the attention of investors who follow the capital goods space. Over the past month, the stock has drifted lower. This has prompted renewed interest in how the company’s fundamentals are holding up. See our latest analysis for Carrier Global. Carrier Global’s share price has lost ground this year, with a 15.8% decline year-to-date and a one-year total shareholder return of -21.1%. Longer-term holders still enjoy solid...

Thinking about whether Assurant is fairly priced? You are not alone, especially with so many investors trying to figure out if they are seeing hidden value or just chasing trends. Recently, Assurant's share price has seen a 3.2% gain over the last week, even after dipping 2.5% this past month, and the stock is up 12.8% over the past year. Long-term investors have been well rewarded, with 84% gains over three years. This price action has come alongside news that Assurant is expanding its...

Xenon Pharmaceuticals (XENE) reported continued unprofitability in its latest quarter and is projected to remain in the red for at least three more years. Over the past five years, losses have grown at an average yearly rate of 37%. However, revenue growth is forecast to accelerate at 72.4% per year, outpacing both the broader US market and the biotech sector. Despite substantial top-line momentum, margins and net profit have yet to improve, keeping earnings quality under pressure. See our...

Curious if Nebius Group stock is truly a bargain or just riding hype? Let’s break down what the numbers and trends actually reveal. After skyrocketing 262.3% year-to-date and 481.8% over the last year, Nebius Group has seen shares fall by 9.3% in the past week and 13.6% in the past month. This hints at shifting sentiment or market uncertainty. Recent news has focused on Nebius Group’s high-profile expansion moves and its push into new cloud technologies, which has caught both investor and...

Wondering if Fiserv is trading at a bargain price or if the market already sees its true potential? Let’s dig in and see where the value story stands. Fiserv’s stock price has seen a dramatic decline recently, dropping nearly 49% over the past month and over 68% year-to-date. This is raising eyebrows about both risk and opportunity. These sharp moves have followed headlines about regulatory shifts impacting the fintech industry and changes in market sentiment toward digital payment...

Cencora (COR) has seen its stock price move slightly this week, catching the eye of investors who are tracking healthcare sector performance. With a steady climb over the past month, the company’s trends invite a closer look at recent results. See our latest analysis for Cencora. Cencora’s strong 13.8% one-month share price return builds on steady gains this year, pushing its latest close to $344.53 and bringing the company’s year-to-date share price return to over 53%. Long-term investors...

Vistra (VST) has been active on multiple fronts lately. The company has kicked off a 20-year nuclear power deal, announced plans to boost natural gas capacity in Texas, and rolled out incremental increases to both common and preferred dividends. See our latest analysis for Vistra. Vistra’s strategic moves have kept its momentum going after a blockbuster twelve months, with a 53% one-year total shareholder return and cumulative five-year returns now topping 900%. The latest 2% dividend hike...

Wondering if Corcept Therapeutics is still a smart buy or if the market has gotten ahead of itself? If you’re curious about getting real value from your investments, this could be the stock to watch. The past year has been good to Corcept, with the stock climbing 31.1% over 12 months and an eye-catching 42.3% year to date. However, recent weeks have seen a pullback of -20.9% for the month and -1.3% in the past week. These price swings come as a result of heightened investor attention, driven...

Wondering if Nordson is really worth its current price tag? You are not alone, as investors keep asking whether the stock is undervalued or just fairly priced in today’s market. Despite climbing 12.4% year to date, Nordson shares have dipped 2.1% over the past week and are down 7.7% for the year, raising fresh questions about risk and growth potential. Recent headlines have put the spotlight on Nordson’s plans to expand its automation solutions through strategic partnerships, fueling both...

Bruker (BRKR) just delivered its third quarter results, revealing a move from net income last year to a net loss in this period, along with a sizable goodwill impairment. The company also revised its full-year outlook lower, citing softer demand and earnings dilution. See our latest analysis for Bruker. Despite the string of recent updates, including lowered guidance and fresh dividend announcements, Bruker’s share price has shown surprising resilience, bouncing more than 29% over the past 90...

Wave Life Sciences recently reported highly significant, dose-dependent reductions in Activin E from its INLIGHT clinical trial of WVE-007 for obesity, sharing the data at its annual analyst and investor Research Day. The company's findings highlight a potential new approach to targeting obesity by reducing visceral fat while preserving muscle mass, and also introduced advancement of its RNA editing candidate WVE-008 for liver disease linked to the PNPLA3-I148M mutation. We'll examine how...

Thinking about buying Amgen and wondering if it's a smart value play right now? You're not alone. Many investors are sizing up whether the company's long-term prospects are already baked into the price, or if there's still room for upside. Amgen's stock price has climbed 1.6% over the last week and is up an impressive 14.4% year-to-date, although it's off by 4.0% compared to this time last year. This reflects both renewed growth optimism and shifts in risk perception among investors. Recent...

Extra Space Storage (EXR) stock performance has caught the eye of investors as shares continue to drift lower this month. With a year-to-date decline of more than 11% and shares currently at $131, many are re-evaluating the company’s valuation and future prospects. See our latest analysis for Extra Space Storage. This recent slide in Extra Space Storage’s share price, including a 7.98% drop over the past month and a 10.55% slide in the last week, reflects fading momentum as the market digests...

Ever wondered if Columbia Banking System is actually a bargain, or if the market has already priced in all its potential? If you're searching for hidden value or warning signs, you're in the right place. The stock has seen slight movement recently, notching a 0.5% gain over the last week even as it remains down 11.9% for the year. This hints at shifting investor optimism or risk perceptions. Media coverage has highlighted steady bank sector volatility and consolidation trends that continue...

Greenfire Resources (NYSE:GFR) just posted a dramatic turnaround, with earnings growth reversing from a 20.2% annual decline over the past five years to a staggering 252.7% increase last year. The company’s net profit margin jumped to 19.1% from 5.1% a year ago, while shares now trade at just 3.3x earnings, which is far below the industry average of 12.8x and the peer average of 19.2x. This comes despite a current share price of $4.47 compared to a fair value estimate of $186.11. Momentum has...

Hims & Hers Health (HIMS) posted strong revenue and earnings growth forecasts, with revenue expected to rise 14.7% per year and earnings projected to climb 27.5% annually. Both figures surpass broader US market trends. While the company’s average annual earnings growth reached 62.2% over the past five years, the most recent year saw a 32.1% expansion, and net profit margins dipped to 6.1% compared to 8.2% a year ago. Investors are weighing a solid profitability record and bright growth...

SBA Communications (SBAC) posted net profit margins of 30.7%, rising from 25.8% the previous year, with annual earnings growth averaging 34.2% over the last five years. More recent earnings growth for the past year came in at 25%. Revenue is forecast to grow at just 3% annually, and earnings are expected to increase by 2% per year. Both of these figures trail the broader US market benchmarks. With a Price-To-Earnings ratio of 24.4x, below both its peer average of 30.5x and the industry...

Joby Aviation (JOBY) just took another step toward future growth by starting propeller blade production at its Dayton facility and teaming up exclusively with Nvidia for advanced autonomous flight technology. Both moves indicate serious ambitions ahead. See our latest analysis for Joby Aviation. After a remarkable climb, Joby’s 1-year total shareholder return is an eye-popping 189%, reflecting immense optimism about the company’s scale-up and new tech partnerships. While recent weeks have...

Curious if Four Corners Property Trust is a bargain or too pricey in today’s market? Let’s break down what’s driving the stock’s value and whether there’s opportunity ahead. Even though the stock slipped 0.1% over the past week and 1.8% in the last 30 days, it is only down 9.8% in the past year, showing signs of resilience amidst a tough environment. Investors have been keeping an eye on rising interest rates and evolving commercial real estate trends, both of which continue to influence...